Azura Ophthalmics focuses on the development of ophthalmic keratolytics for the treatment of ocular conditions.

Azura Ophthalmics

Viewport Meta

IPhone / Mobile Compatible

Euro

Apple Mobile Web Clips Icon

WordPress

WP Rocket

Plausible Analytics

Healthcare

Charles Bosworth

Chief Executive Officer

Marc Gleeson

Vice President Medical Affairs

Eric Kassel

Business Management

Limor Miara

Finance and Administration

Ashwin Agarwal

Heather Preston

Chris Nave

Anat Naschitz

Yair Alster

Founder, Chief Technology Officer and Director

Chief Financial Officer

Hila Epstein-Barash

Chief Research and Development Officer

Chief Medical Officer

Biotechnology Companies With Fewer Than 50 Employees (Top 10K)

Middle East and North Africa (MENA) Companies (Top 10K)

Biotechnology Companies With More Than 10 Employees (Top 10K)

Private Middle East Companies (Top 10K)

Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatment options are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. 

The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.

Brandon BioCatalyst

Grant - Azura Ophthalmics

Brandon Capital

Ganot Capital

OrbiMed

TPG Biotech

Series C - Azura Ophthalmics

Series B - Azura Ophthalmics

Tel Aviv

Israel

Asia

Azura Ophthalmics Announces Enrollment of First Patient in Phase 3 Clinical Trial for AZR-MD-001 in Patients with ...

Azura Ophthalmics to Present New Data Supporting the Potential of AZR-MD-001 to be the First Ophthalmic Keratolytic ...

Selenium disulfide compositions for use in treating meibomian gland dysfunction

Azura Ophthalmics presents new codrugs for eye and dermatological disorders

Compounds and methods for the treatment of ocular disorders

Compositions and methods for the treatment of meibomian gland dysfunction

Instructions for composition and sensitivity

A topical ointment developed for the treatment of Meibomian Gland Dysfunction (MGD) and Evaporative Dry Eye Disease, utilizing Selenium Sulfide to target the pathophysiology of MGD.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 28, 2024 6:06 PM	d6b0d241
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 28, 2024 6:06 PM	86faf497
crunchbase trigger	general	Nov 25, 2024 9:06 AM	34a37d36
crunchbase profile	general	Nov 25, 2024 10:46 AM	f9577cfc
li profile	general
translate crunchbase fundingrounds	general	Nov 26, 2024 11:07 AM	6009b778
peers	general	Sep 28, 2024 6:06 PM	3d141ff0
news basic	general	Sep 28, 2024 6:06 PM	29b32357
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:AZURAOPHTHALMICS

Azura Ophthalmics